Literature DB >> 15939336

MAPK kinase kinases (MKKKs) as a target class for small-molecule inhibition to modulate signaling networks and gene expression.

Gary L Johnson1, Henrik G Dohlman, Lee M Graves.   

Abstract

MAPKs are members of a three-kinase phosphorelay system composed of the MAPK, MAPK kinase (MKK) and MAPK kinase kinase (MKKK). MKKKs phosphorylate and activate MKKs, which in turn phosphorylate and activate MAPKs. Scaffolding proteins organize MKK-MAPK complexes for activation by specific MKKKs and do so in specific locations in the cell. It is the MKKK associated with the scaffolded complex that provides selectivity for activation by upstream stimuli including GTPases, additional kinases and receptors. The demonstration that specific MKKKs also exert control over gene expression by regulating the repertoire of required transcriptional machinery is a newly recognized function for MKKKs. Appreciation of MKKKs as signaling hubs for selectively integrating different upstream stimuli into the control of MAPK networks, and the ability of MKKKs to function as master planners of the transcription factor machinery suggest that MKKK inhibitors will provide selective therapeutic intervention of stimulus-specific MAPK responses.

Mesh:

Substances:

Year:  2005        PMID: 15939336     DOI: 10.1016/j.cbpa.2005.04.004

Source DB:  PubMed          Journal:  Curr Opin Chem Biol        ISSN: 1367-5931            Impact factor:   8.822


  34 in total

Review 1.  Synthetic biology with surgical precision: targeted reengineering of signaling proteins.

Authors:  Vsevolod V Gurevich; Eugenia V Gurevich
Journal:  Cell Signal       Date:  2012-06-01       Impact factor: 4.315

Review 2.  MAP kinase pathways: the first twenty years.

Authors:  Joseph Avruch
Journal:  Biochim Biophys Acta       Date:  2006-11-15

Review 3.  The c-jun kinase/stress-activated pathway: regulation, function and role in human disease.

Authors:  Gary L Johnson; Kazuhiro Nakamura
Journal:  Biochim Biophys Acta       Date:  2007-01-04

4.  Histone deacetylase inhibitor treatment attenuates MAP kinase pathway activation and pulmonary inflammation following hemorrhagic shock in a rodent model.

Authors:  Ashley R Kochanek; Eugene Y Fukudome; Yongqing Li; Eleanor J Smith; Baoling Liu; George C Velmahos; Marc deMoya; David King; Hasan B Alam
Journal:  J Surg Res       Date:  2011-07-05       Impact factor: 2.192

Review 5.  Cytokine-effects on glucocorticoid receptor function: relevance to glucocorticoid resistance and the pathophysiology and treatment of major depression.

Authors:  Thaddeus W W Pace; Fang Hu; Andrew H Miller
Journal:  Brain Behav Immun       Date:  2006-10-27       Impact factor: 7.217

Review 6.  The potential of p38 MAPK inhibitors to modulate periodontal infections.

Authors:  Keith L Kirkwood; Carlos Rossa
Journal:  Curr Drug Metab       Date:  2009-01       Impact factor: 3.731

7.  F-box only protein 31 (FBXO31) negatively regulates p38 mitogen-activated protein kinase (MAPK) signaling by mediating lysine 48-linked ubiquitination and degradation of mitogen-activated protein kinase kinase 6 (MKK6).

Authors:  Jia Liu; Liang Han; Bin Li; Jie Yang; Michael S Y Huen; Xin Pan; Sai Wah Tsao; Annie L M Cheung
Journal:  J Biol Chem       Date:  2014-06-16       Impact factor: 5.157

Review 8.  The discovery of novel experimental therapies for inflammatory arthritis.

Authors:  Charles J Malemud
Journal:  Mediators Inflamm       Date:  2010-03-18       Impact factor: 4.711

9.  Clinical activities of the epidermal growth factor receptor family inhibitors in breast cancer.

Authors:  Elizabeth S Henson; James B Johnston; Marek Los; Spencer B Gibson
Journal:  Biologics       Date:  2007-09

10.  The roles of ASK family proteins in stress responses and diseases.

Authors:  Kazuki Hattori; Isao Naguro; Christopher Runchel; Hidenori Ichijo
Journal:  Cell Commun Signal       Date:  2009-04-24       Impact factor: 5.712

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.